[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100355051":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":21,"locations":30,"responsibleParty":44,"collaborators":20,"id":48,"slug":20,"hasResults":49,"nctId":50,"briefTitle":51,"officialTitle":52,"acronym":20,"eligibilityCriteria":53,"healthyVolunteers":54,"sex":55,"minAge":56,"maxAge":57,"enrollmentInfo":58,"targetDuration":20,"studyType":61,"phases":62,"briefSummary":64,"conditions":65,"keywords":67,"overallStatus":33,"whyStopped":20,"lastUpdateSubmitDate":70,"lastUpdatePostDateStruct":71,"startDateStruct":74,"completionDateStruct":76,"leadSponsor":78,"locationsCount":79},{"fullName":5,"class":6},"Chinese University of Hong Kong","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"prednisolone","EXPERIMENTAL","prednisolone oral 10 mg\u002Fday from day one of the subsequent menstrual cycle to day LH plus 7. Women will be then given a tailing off dose of 5 mg\u002Fday for 3 days followed by 2 mg\u002Fday for 3 days and then 1 mg\u002Fday for 3 days.",[13],"Drug: Prednisolone",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"DRUG","Prednisolone","prednisolone oral 10 mg\u002Fday from day one of the subsequent menstrual cycle to day LH 7 of that cycle. Then, the participants will be given a tailing off dose of 5 mg\u002Fday for 3 days followed by 2 mg\u002Fday for 3 days and then 1 mg\u002Fday for 3 days.",[9],null,[22,27],{"name":23,"role":24,"phone":25,"phoneExt":20,"email":26},"Stacey Wong, BSc","CONTACT","85235051764","staceywong@cuhk.edu.hk",{"name":28,"role":24,"phone":25,"phoneExt":20,"email":29},"Pui Wah Jacqueline Chung, MBBS","jacquelinechung@cuhk.edu.hk",[31],{"facility":32,"status":33,"city":34,"state":20,"zip":20,"country":34,"cosmosGeoPoint":35,"geoPoint":40,"contacts":41},"The Chinese University of Hong Kong","RECRUITING","Hong Kong",{"type":36,"coordinates":37},"Point",[38,39],114.17469,22.27832,{"lat":39,"lon":38},[42,43],{"name":23,"role":24,"phone":25,"phoneExt":20,"email":26},{"name":28,"role":24,"phone":25,"phoneExt":20,"email":29},{"type":45,"investigatorFullName":46,"investigatorTitle":47,"investigatorAffiliation":5,"oldNameTitle":20,"oldOrganization":20},"PRINCIPAL_INVESTIGATOR","Chung Pui Wah Jacqueline","Associate Professor","100355051",false,"NCT03902912","Effect of Prednisolone Treatment on Uterine Natural Killer Cells","Effect of Prednisolone Treatment on Uterine Natural Killer Cells and Endometrial Angiogenesis in Recurrent Miscarriage Around the Time of Embryo Implantation","Inclusion Criteria:\n\n1. Women with a history of 3 or more consecutive miscarriages\n2. Women younger than 40 years old\n\nExclusion Criteria:\n\n1. Allergy to prednisolone\n2. Women who have any uterine anomaly\n3. Antiphospholipid syndrome\n4. Hydrosalpinx\n5. Thrombophilia\n6. Abnormal thyroid function tests\n7. women with diabetes,",true,"FEMALE","18 Years","40 Years",{"count":59,"type":60},84,"ESTIMATED","INTERVENTIONAL",[63],"PHASE3","This study aims to investigate the role of uNK cells and the association with prednisolone.",[66],"Recurrent Miscarriage",[68,69],"recurrent miscarriage","prednisolone treatment","2025-03-19",{"date":72,"type":73},"2025-03-21","ACTUAL",{"date":75,"type":73},"2019-07-30",{"date":77,"type":60},"2028-04-30",{"name":5,"class":6},1]